Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Andres Ort

801 indexed publications match this author name.

ORCID
Not found in stored metadata
OpenAlex
Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Publication history

Current perspectives in the pharmacological treatment of gambling disorder: psychedelics and beyond.Expert opinion on pharmacotherapy · 2026-11-13Psilocybin enhances conditioned place preference learning in planarians.Behavioural pharmacology · 2026-11-13Connectedness as a candidate pathway linking psilocybin retreat experiences to sustained wellbeing: a prospective naturalistic studyFrontiers in psychiatry · 2026-11-12NeuroGuard: Psilocybin Trial for Preventing Chemo-induced NeuropathyClinicalTrials.gov · 2026-11-12A Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress DisorderClinicalTrials.gov · 2026-11-12From Rapid Synaptic Events to Lasting Antidepressant States: Convergent and Divergent Mechanisms of Ketamine and Psychedelics.The Journal of neuroscience: the official journal of the Society for Neuroscience · 2026-11-11The "dark magic mushroom" co-produces amatoxins and psilocybin.Current biology: CB · 2026-11-11Psilocybin Recovery Intervention for Stopping Methamphetamine UseClinicalTrials.gov · 2026-11-09Pharmacist Guide to Psilocybin and Psychedelic-Assisted Psychotherapy.American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists · 2026-11-06Psilocybin modulates nucleus accumbens activity via astrocytic transcriptional regulation.Experimental & molecular medicine · 2026-11-05Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring OpioidsClinicalTrials.gov · 2026-11-05The Bicuspid Aortic Valve Within the Therapeutic Window of Cannabis, Tryptamines, and Novel Neuroplastogen Analogs: A Mechanistic Risk Analysis Anchored to a Reconstructed openSNP Genotype CohortPreprints.org · 2026-11-03Estimations of the Vaporization Enthalpies of a Series of Licit and Illicit Drugs by Synthetic Analysis and Group AdditivityResearch Square · 2026-11-03Psilocybin-Assisted Therapy for Cancer-Related Psychological and Existential Distress in Adults with Cancer: An Integrative Systematic Review.Journal of pain & palliative care pharmacotherapy · 2026-11-03TRIP - TReatment to Improve Depression and/or Anxiety Using Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance TherapyClinicalTrials.gov · 2026-11-03TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer SurvivorsClinicalTrials.gov · 2026-11-03A multi-institutional investigation of psilocybin's effects on mouse behavior.Nature neuroscience · 2026-11-02Furthering the Understanding of Psilocybin Use and Molecules Relevant to Depression and Schizophrenia.The American journal of psychiatry · 2026-11-01Psilocybin Use in Psychiatry: Clinical Practice and Public Health Implications.The American journal of psychiatry · 2026-11-01How Psilocybin Alters Consciousness: Psychedelics can create a "hidden order" in brain activity that could explain how these drugs affect our sense of self.Scientific American · 2026-11-01Safety and efficacy of psilocybin-assisted therapy for alcohol use disorder: Open-label extension of a phase II randomized controlled trialDrug and Alcohol Dependence · 2026-11-01The Fireside Database: Large-scale evidence from 25,419 psychedelic support interactions.Science advances · 2026-10-30Effects of psilocybin with psychological support on anhedonia in treatment-resistant depression: A randomized controlled pilot trial.Journal of affective disorders · 2026-10-30Multi-scale effects of single-dose psilocybin in the macaque brainResearch Square · 2026-10-29A Phase 2b Double-blind, Randomized, Low-dose Comparator-controlled Clinical Trial to Assess the Efficacy and Safety of NPX-5 in Psilocybin-assisted Psychotherapy for the Treatment of Adjustment Disorder Associated With Cancer.ClinicalTrials.gov · 2026-10-29A Phase 2a Study of Group Retreat Psilocybin Therapy for Cancer-Related Anxiety and DepressionClinicalTrials.gov · 2026-10-29Quantum Chemical Topology and Energetic Analysis of Psychedelic and Non-Psychedelic Ligands in Coordination-Sphere Models of the Human 5-HT2A ReceptorResearch Square · 2026-10-28Psychedelics and psychosis: A systematic review of recent-era studies (1984-2025).Journal of psychopharmacology (Oxford, England) · 2026-10-27Magic pathways: the genes and enzymes of psilocybin biosynthesis.Microbiology and molecular biology reviews: MMBR · 2026-10-27Single Intranasal Administration of the Psychedelic Mebufotenin for Treatment-Resistant Depression: A Randomized Clinical Trial.JAMA · 2026-10-26Sex-related differences in outcomes following psilocybin or escitalopram: a Bayesian secondary analysis.Psychopharmacology · 2026-10-26Psilocybin in Chronic Low Back Pain: An Integrative Study of Lab-Based Mechanisms and Real-World Physical Therapy OutcomesClinicalTrials.gov · 2026-10-26Direct Quantitation of Psilocybin and Psilocin by 1H and 31P qNMR in Wild Psilocybe from GreeceACS omega · 2026-10-24Preparing the body for psilocybin therapy: receptive and generative interoception in cancer patientsFrontiers in psychiatry · 2026-10-24Sustained antidepressant-like effects of psychedelics through 5-HT2AR-β-arrestin signaling.Nature neuroscience · 2026-10-23A Multi-site Randomized Controlled Trial of Psilocybin for Treatment-Resistant Depression (TRD) in VeteransClinicalTrials.gov · 2026-10-23Psilocybin and Inflammatory and Mitochondrial Stress Markers in Parkinson Disease: A Nonrandomized Clinical Trial.JAMA psychiatry · 2026-10-21A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Psilocybin in Adults With Major Depressive Disorder (MDD)ClinicalTrials.gov · 2026-10-21Direct Quantitation of Psilocybin and Psilocin by H and P qNMR in Wild from Greece.ACS omega · 2026-10-20Activating Neuroplasticity to ENHANCE the Perception Box Expanding Effects of PsilocybinClinicalTrials.gov · 2026-10-20Psilocybin for anhedonia in unipolar and bipolar depression: A systematic review of clinical and preclinical evidence.Journal of psychiatric research · 2026-10-19Investigation of the pharmacological and circuit basis for psychedelic drug effects on interval timing in mice.Psychopharmacology · 2026-10-19Psychoplastogens to Reduce Persistent Cognitive Symptoms for Traumatic Brain Injury as a Chronic Condition.Journal of neurotrauma · 2026-10-19A Pilot Mechanistic RCT of Psilocybin With Mindfulness-based Therapy vs Support for Posttraumatic Stress Disorder (PTSD)ClinicalTrials.gov · 2026-10-19Serotonin 1B receptors expressed on forebrain excitatory neurons mediate the post-acute anxiolytic response to psilocybin in mice.Psychopharmacology · 2026-10-17French psychiatric caregivers' perceptions of psychedelics: A national survey.L'Encephale · 2026-10-16Stroboscopic light stimulation as a controllable probe of the psilocybin state: a mechanistic framework and a falsifiable predictionFrontiers in pharmacology · 2026-10-16Aspirational Autonomy and Psychedelic-Assisted Therapy in Advanced Cancer: Ethical Lessons from Clinical Cases.The oncologist · 2026-10-155-HT2A receptors in layer 5 pyramidal neurons mediate the neuroplastic but not the hallucinogenic effects of psilocybin.Nature neuroscience · 2026-10-15Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled TrialClinicalTrials.gov · 2026-10-15Mechanistic Evaluation of Psilocybin in Neurodegenerative Disorders: Relevance of 5-HT2A Receptors and Downstream Pathways.CNS & neurological disorders drug targets · 2026-10-14The Hidden Therapeutic Bridge: Exploring Psilocybin's Role in Depression, Inflammation, and Pain - A Narrative Review.Current neuropharmacology · 2026-10-14Acute anxiogenic effects of psilocybin and the related tryptamine, norbaeocystin, in male and female rats.Psychopharmacology · 2026-10-13Mystical experiences mediate the effects of psilocybin-assisted psychotherapy + mindfulness-based stress reduction on trait mindfulness and depression symptoms: mechanistic results from a randomized controlled trialJournal of Affective Disorders Reports · 2026-10-11Molecular Mechanism of Psilocybin-Induced Longevity: The c-Fos-SIRT6 Epigenetic AxisResearch Square · 2026-10-09Music for psilocybin therapy and the temporal arc of psychedelic experienceScientific Reports · 2026-10-08Acute psilocybin or ethocybin leads to a sustained increase in Pavlovian aversion memory in male miceFrontiers in pharmacology · 2026-10-07Therapists’ Perspectives on the Psychotherapeutic Support in Psilocybin Treatment for Major Depressive Disorder: Insights from a Randomized Controlled TrialResearch Square · 2026-10-05Psychedelics and disorders of consciousness: a new frontier in neurotherapeutics.Molecular psychiatry · 2026-10-03Embeddedness under psilocybin.Nature neuroscience · 2026-10-01Oregon’s State-Regulated Psilocybin Services: Early Real-World Safety SignalsPsyArXiv · 2026-10-01Psilocybin as serotonergic therapy in epilepsy: Narrative review of potentials and limitations.British journal of clinical pharmacology · 2026-10-01The Safety and Acceptability of Psilocybin With Support and With Massed Prolonged Exposure Therapy for PTSDClinicalTrials.gov · 2026-10-01Large-Scale and Local Functional Connectivity Changes following Psilocybin Administration in Methamphetamine Use Disorder.AJNR. American journal of neuroradiology · 2026-10-01Mescaline Alters Cerebellar Function, Global Connectivity, and Frequency-Selective Acoustic Gating: A BOLD fMRI Study in Awake Rats.Neuroscience bulletin · 2026-10-01Worsening of Depression and Anxiety With Psilocybin: A Case Report in Cyclothymia.The Journal of clinical psychiatry · 2026-09-30Psilocybin and ayahuasca in treatment-resistant depression: clinical evidence, methodological constraints and ethical challenges: a narrative reviewFrontiers in psychiatry · 2026-09-30U.S. Veterans and Psychedelics: Prevalence of Use and Policy Preferences.Rand health quarterly · 2026-09-29Targeting the serotonin 1B receptor for the treatment of depression and anxiety.Expert opinion on therapeutic targets · 2026-09-28Age moderates the relationship between psychedelic use and mental health in naturalistic settingsScientific Reports · 2026-09-24Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility StudyClinicalTrials.gov · 2026-09-23Curious about Psilocybin? Prevalence and correlates of interest among adults with chronic pain.Authorea Preprints · 2026-09-21Pharmacokinetics and safety of a modified-release psilocybin formulation: A SAD Phase I trial in normal-weight and overweight/obese participants.British journal of clinical pharmacology · 2026-09-21An Open-Label, Dose-Escalation Trial of Psilocybin-Assisted Therapy for Bipolar II Depression.The Journal of clinical psychiatry · 2026-09-21A Case of Acute Mania and Rhabdomyolysis Associated With Long-Term, Daily Psilocybin Use.Journal of clinical psychopharmacology · 2026-09-21Psychedelics and suicidality: A double-edged sword - risks, mechanisms, and moving forward.European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology · 2026-09-19Exploring the Therapeutic Potential of Psilocybin: A Comprehensive Review of Clinical Trial Evidence and Implications for Rescheduling.Mini reviews in medicinal chemistry · 2026-09-18Perceptions and Attitudes on Psilocybin-Assisted Therapy among Underrepresented People with Cancer.Journal of pain and symptom management · 2026-09-18High ventilation breathwork as a non-pharmacological model for inducing psychedelic-like states: expert evaluations of therapeutic potential and risk.Npj mental health research · 2026-09-17Psilocybin restores social novelty investigation in male SAPAP3 knockout mice and engages prefrontal-hippocampal circuitry.Molecular psychiatry · 2026-09-17Surrender, disidentification, and reappraisal: a qualitative comparison of psilocybin responders and non-responders in treatment-resistant OCDFrontiers in psychiatry · 2026-09-165-HT2A receptor activation is dispensable for psilocybin-induced fear extinction and neuroplasticity in mice.Chinese medical journal · 2026-09-15Resetting the hippocampal buffer: a neurocognitive account of psychedelic therapy for anxiety-related psychopathology.Psychopharmacology · 2026-09-15Implications of Potential US FDA Approval of Psychedelics or Psychedelic-Adjacents Such as Ibogaine for Pharmacy in Japan.Cureus · 2026-09-13[The use of psychedelics in psychiatry].Orvosi hetilap · 2026-09-13Lifetime classic psychedelics use is associated with positive environmental attitudes and adopting a vegetarian dietScientific Reports · 2026-09-11Cardiac Arrhythmia Associated with Psychoactive Drugs: An analysis of the FDA Adverse Event Reporting SystemmedRxiv · 2026-09-10Psilocybin selectively suppresses novelty-induced grooming via 5-HT2B receptors: A microstructure analysis in Wistar rats.Progress in neuro-psychopharmacology & biological psychiatry · 2026-09-09Psychedelic 4-AcO-DMT attenuated looming-induced freezing behaviors by activating PrL CaMKIIα neurons in mice.Molecular psychiatry · 2026-09-09A Two-Threshold Model of Psilocybin Response Explains Variability in Psychedelic-Assisted Therapy for Treatment-Resistant DepressionResearch Square · 2026-09-09Craving Reduction and Smoking Outcomes in Psilocybin-Assisted and Standard Cessation Care.Revista brasileira de psiquiatria (Sao Paulo, Brazil: 1999) · 2026-09-09Psilocybin as a treatment for repetitive mild head injury: evidence from neuroradiology and molecular biologyCommunications Biology · 2026-09-08Who Is Reached by Supervised Psilocybin Services? Oregon Services Versus National Psilocybin UsemedRxiv · 2026-09-07Psilocybin as an emerging anxiolytic: mechanisms, evidence, and open questions.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-09-06Daily briefing: Psilocybin blocks side-effect of chemotherapy in mice.Nature · 2026-09-04Psilocybin-induced changes in electroencephalography link acute and long-term effects.Journal of psychopharmacology (Oxford, England) · 2026-09-04One dose of Psilocybin modulates Brain Activity among Depressive patients: Preliminary Neuroimaging Results from the PSILODAC StudyEuropean psychiatry: the journal of the Association of European Psychiatrists · 2026-09-04Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence in Patients Diagnosed With Early-stage Breast Cancer and Ovarian Cancer in RemissionClinicalTrials.gov · 2026-09-04Psilocybin prevents chemotherapy-induced peripheral neuropathy through mitochondrial trafficking preservation.Science (New York, N.Y.) · 2026-09-03A response to the letter to editor: Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy.Journal of affective disorders · 2026-09-02Through the Looking-Glass: A Scoping Review of Psychological Mechanisms of Psychedelic-Assisted Therapy for Substance Use DisordersCurrent Addiction Reports · 2026-09-02Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for Alcohol Use DisorderClinicalTrials.gov · 2026-09-02The Role of the Subjective Experience in Supporting Positive Effects Following Psilocybin: a Randomized, Controlled Clinical Trial Using Risperidone in Healthy AdultsClinicalTrials.gov · 2026-09-02Age and Cannabis Co-Use Are Associated with Differences in Experience and Perceived Benefits of Psilocybin: A Retrospective Study.Journal of psychoactive drugs · 2026-09-02Psilocybin, From Ancestral Use to Therapeutic Potential: A Multidimensional Review of Its Pharmacological Basis and Current Perspectives.Human psychopharmacology · 2026-09-01Factors Associated with Intentions to Use Psilocybin for Mental Health in Relation to Psychotherapy, Psychiatric Medications, and Natural/Synthetic Options.Journal of psychoactive drugs · 2026-09-01Mycotoxins in Basidiomycete Mycelium and Fruiting Bodies: Implications for Eu Novel Food Assessment and Selected International Regulatory Frameworks.Comprehensive reviews in food science and food safety · 2026-09-01AMCP Market Insights: Optimizing managed care approaches to treatment-resistant depression.Journal of managed care & specialty pharmacy · 2026-09-01Contribution of the Serotonin 5-HT2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat Stress.Neuropsychopharmacology reports · 2026-09-01Genome-based optimization of psilocybin and N,N-dimethyltryptamine biosynthetic pathways in E. coli using CRISPR-associated transposases.Metabolic engineering · 2026-09-01Differential effects of psilocybin derivatives on fentanyl-induced conditioned place preference in male and female mice.Journal of psychopharmacology (Oxford, England) · 2026-08-30Development of a Physiologically Based Pharmacokinetic/Pharmacodynamic Model of Psilocybin/Psilocin from Psilocybe cubensis (Magic Mushroom) in Treatment-Resistant Depression.European journal of drug metabolism and pharmacokinetics · 2026-08-28Pilot study comparing the effects of high dose THC to high dose psilocybin and placebo in the set and setting of a classic psychedelic therapy session.Psychopharmacology · 2026-08-27Medical and Psychiatric Consultation for Patients Considering State-Regulated Psilocybin Services: A Risk-Reduction Model and Two Illustrative CasesResearch Square · 2026-08-26Aquahenosis: a non-pharmacological altered state of consciousness induced by floatation-REST in individuals with anxiety and depression.Neuroscience of consciousness · 2026-08-26Mystical and affective features of naturalistic psychedelic experiences: A comparison of dictionary-based and LLM-based text analysis methodsResearch Square · 2026-08-25Psilocybin collapses visual change detection and drives cortical dynamics toward a state of surprisebioRxiv · 2026-08-25Beyond head-twitch response: Acute psilocybin affects spontaneous behaviors in rats in a dose-dependent manner.Journal of psychopharmacology (Oxford, England) · 2026-08-25Toward an Optimal Framework for Psilocybin Regulation: A Comparison of State Regulatory Approaches Across Key Dimensions.The Journal of legal medicine · 2026-08-25Adverse Effect-Related Language in Recreational Psychedelic and non-Psychedelic Substance Experience Reports.Journal of studies on alcohol and drugs · 2026-08-22Complex Fatal Self-Harm Under Psilocybin Intoxication: Suicidal Manner of Death or Not?Academic forensic pathology · 2026-08-21The trials of translating psilocybin treatment from research to practice.Nature medicine · 2026-08-21Low-dose lysergic acid diethylamide alters subjective visual perception but not visual contrast surround suppression.Neuroscience of consciousness · 2026-08-20Safety and Mental Health Outcomes of Oregon State-Regulated Psilocybin ServicesJAMA Network Open · 2026-08-19An Exploratory Pilot Study of Palliadelic Treatment to Reduce Psychological Distress in People With Pancreatobiliary and Other Advanced Gastrointestinal CancersClinicalTrials.gov · 2026-08-19Psychedelics align brain activity with context.Nature · 2026-08-19The Abuse Liability of Classic Psychedelics: A Methodological Critique and Assessment of the Quality of Evidence of Recent StudiesCurrent Addiction Reports · 2026-08-18Psilocybin-assisted psychotherapy for substance use disorders as a complex intervention: A systematic review of efficacy, mechanisms and psychotherapeutic frameworks.Journal of psychopharmacology (Oxford, England) · 2026-08-17Defining 'psychedelic'.Journal of psychopharmacology (Oxford, England) · 2026-08-17Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and SuicidalityClinicalTrials.gov · 2026-08-12Effects of naturalistic psychedelic use on executive functioning: An online survey of lifetime history and recent use in university students.Progress in neuro-psychopharmacology & biological psychiatry · 2026-08-11Psychedelics and astrocytes: a hypothesis-driven perspective on neuro-glial integration, network plasticity, and neuroimmune reprogramming.Molecular psychiatry · 2026-08-11Circulating MicroRNAs and Their Associations with Neurotrophic, Inflammatory and Glutamate Markers in Healthy VolunteersbioRxiv · 2026-08-10Temporal effects of a single oral dose of psilocybin on plasma circulating miRNAs in healthy young adultsbioRxiv · 2026-08-10Psilocybin acutely dissociates cognitive and affective empathy, with empathic concern predicting persisting positive psychological effectsbioRxiv · 2026-08-10An Open-Label Trial Protocol to Test Menstrual Cycle Effects and Tolerance to Low-Dose Psilocybin in Healthy Menstruating Persons.Pharmacology · 2026-08-10A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10A Phase III, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10'So many relationships in the room': Participant perspectives on the affordances and challenges of co-therapy in psychedelic assisted therapy.Psychology and psychotherapy · 2026-08-10Feasibility and Tolerability of Psilocybin for Phantom Limb Pain.The journal of pain · 2026-08-07Correspondence: "Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy".Journal of affective disorders · 2026-08-06Psilocybin-assisted therapy for treatment-resistant major depressive disorder in a public healthcare setting: a randomized controlled trial.Nature medicine · 2026-08-06Psychedelics and women's mental health: the effects of female sex hormones on psychedelics' efficacy and tolerability.Molecular psychiatry · 2026-08-04Where is the sweet spot for psychedelic-enhanced fear extinction? An integrative quantitative synthesis of dose-effect patterns in rodent models.Journal of psychopharmacology (Oxford, England) · 2026-08-03Psilocybin for Fear of Cancer RecurrenceSupportive Care in Cancer · 2026-08-01Ethical Complexities and Best Practices in Informed Consent Processes for Psilocybin Services: A Qualitative StudyNeuroethics · 2026-08-01Beyond psilocybin: Do magic mushroom preparations contain other compounds with pharmacological effects?Authorea Preprints · 2026-07-30Identifying factors that contribute to the behavioral effects of psilocybin in preclinical mouse modelsbioRxiv · 2026-07-28Estimating Cardiac 5-HT2B Safety Margins for Repeated Low-Dose Psilocybin Using an Exposure-Response ModelbioRxiv · 2026-07-23A randomized, double-blind, placebo-controlled single-ascending-dose study to identify a non-hallucinogenic dose of psilocybin in healthy adultsmedRxiv · 2026-07-19Psychedelic Therapies in the Management of Post-Traumatic Stress DisorderJournal of Education Health and Sport · 2026-07-16Uncovering the spatiotemporal structure of neural avalanches through optimal transport and dynamic time warpingbioRxiv · 2026-07-16MDMA and Psilocybin-Assisted Therapy in Australia: Early Real-World Prescribing, Safety Monitoring and Regulatory DevelopmentsScienceOpen Preprints · 2026-07-12Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical DevelopmentBiomolecules · 2026-07-03Sexual identity as a moderator of associations between lifetime MDMA/ecstasy or psilocybin use and mental health outcomes: An exploratory analysis of a nationally representative sample using NSDUH 2015-2019Research Square · 2026-07-02Convergent biosynthesis of psilocybin in an ectomycorrhizal lineage: is the psychoactive end-product the selected trait?EcoEvoRxiv · 2026-07-01Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic CircuitsHuman Brain Mapping · 2026-07-01Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in ratsCell Reports Medicine · 2026-07-01Are we hallucinating or can psychedelic drugs modulate the immune system to control inflammation?British journal of pharmacology · 2026-07-01Divergent changes in perturbation-induced brain reconfiguration following depression treatment with psilocybin and escitaloprambioRxiv · 2026-06-26Psilocybin-assisted Existential, Attachment and Relational (PEARL) Therapy for Caregivers of Patients With Advanced Cancer: A Phase II Open-Label TrialClinicalTrials.gov · 2026-06-23Psilocybin for PTSD With or Without Psychotherapy: A Pilot Study of Safety and EfficacyClinicalTrials.gov · 2026-06-22Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Phase II Open-Label TrialClinicalTrials.gov · 2026-06-22Sex-Specific Effects of Psilocybin Versus Escitalopram on Anxiety and Anhedonia: A Bayesian Reanalysis of Antidepressant Treatment OutcomesResearch Square · 2026-06-19Distinct brain responses to psilocybin and escitalopram in depression captured by the Fluctuation-Dissipation TheorembioRxiv · 2026-06-16EEG microstate dynamics during psilocybin intoxication relate to acute experience and persisting psychological changesbioRxiv · 2026-06-12Prolonged Grief Symptom Outcomes During At-Home Ketamine-Assisted Therapy: A Real-World Retrospective Analysis of 503 AdultsResearch Square · 2026-06-02Patient perceptions towards psychedelics for musculoskeletal pain: A cross-sectional surveymedRxiv · 2026-06-01Sex-dependent developmental changes in behavior, brain structure, functional connectivity, and sensory perception following exposure to psilocybin during adolescence.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-06-01Therapeutic advances in fibromyalgia: one year in review 2026.Clinical and experimental rheumatology · 2026-06-01Environmental and Internal Gating of Memory: ARCH Multiplicative Threshold Framework for Encoding and RetrievalPreprints.org · 2026-05-26265 Self-reported rates of psilocybin use in North Florida, 2012 to presentJournal of clinical and translational science · 2026-05-20361 Effect of intravenous psilocybin on mechanical hypersensitivity in a rat model of reserpine-induced chronic centralized painJournal of clinical and translational science · 2026-05-20Exploring the Safety, Acceptability, and Efficacy of Psilocybin Among Non-Small Cell Lung Cancer Patients With Major Depressive Disorder: A Proof-of-Concept Trial (DREAM LUNG STUDY)ClinicalTrials.gov · 2026-05-14Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of CareCurrent Psychiatry Reports · 2026-05-14Safety and Efficacy of Psilocybin in the Management of Treatment-Resistant Depression: A Systematic ReviewResearch Square · 2026-05-11The Safety and Efficacy of Psilocybin Therapy Compared to Low-dose Control in Reducing Depressive Symptoms in Patients With COPD, ALS, MS, or APD.ClinicalTrials.gov · 2026-05-08Characterizing Resting-State Brain Dynamics with Frequency-Resolved EEG Microstates: Parallel Analyses of Psilocybin Microdosing and Acute Inhaled DMTbioRxiv · 2026-05-08Psilocybin in the Treatment of Cocaine Use DisorderJAMA Network Open · 2026-05-07Induction Protocol for Psilocybin-Assisted Therapy in Treatment-Resistant Depression (TRD): A Pilot StudyClinicalTrials.gov · 2026-05-06Pharmacotherapeutic Management of Depression in Patients With Cancer: A Review of Mechanistic and Clinical Evidence.Cancer reports (Hoboken, N.J.) · 2026-05-01Acute Cardiovascular Effects of Psilocybin: A Pooled Analysis of 14 Studies with Safety RecommendationsmedRxiv · 2026-04-30Lysergic Acid Diethylamide (LSD) in Palliative Care: a Randomised, Double-blind, Active-placebo Controlled Phase II Study (LPC-Study)ClinicalTrials.gov · 2026-04-29The Ecstasy of Gold in Neurodiversity: Focus on the Use of Psychedelics in Autism Spectrum DisorderPreprints.org · 2026-04-29A128-Channel Wireless Wearable Myolink (W2 Myolink): Functional Characteristics and Multidisciplinary ExperimentsResearch Square · 2026-04-28Psilocybin-Enhanced Psychotherapy for Methamphetamine Use DisorderClinicalTrials.gov · 2026-04-22Distinct Modulatory Effects on Affective Biases by Different Serotonergic Psychedelics and MDMA in Male Rats: Possible Implications for Antidepressant EffectsbioRxiv · 2026-04-22Sustained Effects of Low-to-Moderate Doses of Psilocybin on Brain ConnectivitymedRxiv · 2026-04-20Comparative Medico-Legal Frameworks for Psilocybin Regulation: A March 2026 UpdatePreprints.org · 2026-04-20Psilocybin’s Kinematic Effect on Manual DexterityResearch Square · 2026-04-15Psilocybin in Older Adults: Therapeutic Opportunities in Inflammation-Driven Disorders of Aging-From Depression to NeurodegenerationPreprints.org · 2026-04-15CAPSI - Cancer Related Major Depression Treated With a Single Dose of Psilocybin: A Multicenter Randomized Placebo Controlled Double Blind Clinical TrialClinicalTrials.gov · 2026-04-13Psilocybin acutely reduces low-frequency BOLD power and frequency-specific connectivitybioRxiv · 2026-04-13Altered States of Consciousness and the Subconscious Mind: A Comprehensive Comparative Review of Disciplines, Neurobiological Mechanisms, Clinical Applications, and Philosophical Frameworks - Including Life Between Lives and Transpersonal HypnotherapyPreprints.org · 2026-04-07Psilocybin: Wirksam, aber kein WundermittelMMW - Fortschritte der Medizin · 2026-04-01Effects of psilocybin and chronic mild stress on microglial activation in rat spinal cord: an ex vivo analysis.Pharmacological reports: PR · 2026-04-01Engaging Mood Brain Circuits With Psilocybin: a Randomized Neuroimaging Trial in DepressionClinicalTrials.gov · 2026-03-30Psychedelics and Mental Health in Endurance Athletes: A Cross-Sectional Study in Brazil.Journal of psychoactive drugs · 2026-03-20Editorial: Psychedelic substances and neurological diseases: from basics to clinical applicationFrontiers in Pharmacology · 2026-03-15Age moderates the relationship between psychedelics use and mental health in naturalistic settingsResearch Square · 2026-03-10

Author directory

Robin Carhart-Harris178 publicationsDavid Nutt122 publicationsDavid Erritzøe85 publicationsFranz X. Vollenweider85 publicationsRoland R. Griffiths84 publicationsMatthew W. Johnson71 publicationsKatrin H. Preller64 publicationsFrederick S. Barrett61 publicationsGitte M. Knudsen58 publicationsLeor Roseman55 publicationsJames Rucker49 publicationsAlbert Garcia-Romeu46 publicationsTomáš Páleníček45 publicationsPatrick M. Fisher44 publicationsSandeep M. Nayak43 publicationsDea Siggaard Stenbæk42 publicationsJoshua D. Rosenblat42 publicationsKim P. C. Kuypers41 publicationsNatasha L. Mason38 publicationsPeter S. Hendricks38 publicationsAlan K. Davis36 publicationsDavid Bryce Yaden35 publicationsMatthias E. Liechti34 publicationsChristopher Timmermann33 publicationsJohns Hopkins University33 publicationsMuhammad Ishrat Husain33 publicationsBrice Ozenne32 publicationsGuy M. Goodwin30 publicationsHannes Kettner30 publicationsRoger S. McIntyre30 publicationsDirk Hoffmeister29 publicationsJohannes G. Ramaekers29 publicationsMichael P. Bogenschutz29 publicationsStephen Ross29 publicationsErich Seifritz27 publicationsRobert B. Kargbo27 publicationsBrian Anderson26 publicationsXiaohui Wang26 publicationsCharles D. Nichols25 publicationsDrummond E-Wen McCulloch25 publicationsJavier González-Maeso25 publicationsMartin Korsbak Madsen25 publicationsRichard J. Zeifman25 publicationsAllan H. Young24 publicationsGabrielle Agin-Liebes24 publicationsMartin Kuchař24 publicationsMorten L. Kringelbach24 publicationsNathan D. Sepeda24 publicationsPaul Liknaitzky24 publicationsFriederike Holze23 publicationsNatalie Gukasyan23 publicationsRAFAEL GUIMARÃES DOS SANTOS23 publicationsGustavo Deco22 publicationsScott Aaronson22 publicationsAdam L. Halberstadt21 publicationsBrian S. Barnett21 publicationsBruna Giribaldi21 publicationsJacob S. Aday21 publicationsJaime E. C. Hallak21 publicationsManoj Doss21 publicationsOlivia Carter21 publicationsOtto Simonsson21 publicationsBenjamin Kelmendi20 publicationsJiřı́ Horáček20 publicationsMichael Kometer20 publicationsAlex Kwan19 publicationsBernard Lerer19 publicationsMatthew B. Wall19 publicationsRoland A. Fischer19 publicationsRotem Petranker19 publicationsCharles L. Raison18 publicationsDavid E. Nichols18 publicationsEnzo Tagliazucchi18 publicationsFelix Müller18 publicationsFilip Tylš18 publicationsMendel Kaelen18 publicationsRobert A. Schoevers18 publicationsAlexander M. Sherwood17 publicationsAmanda Feilding17 publicationsChristopher S. Stauffer17 publicationsDavid J. Hellerstein17 publicationsFernando Rosas17 publicationsJeffrey Guss17 publicationsMilan Scheidegger17 publicationsTomislav Majić17 publicationsWilliam A. Richards17 publicationsClaire J. Foldi16 publicationsGeyer MA16 publicationsJason B. Luoma16 publicationsKevin F. Boehnke16 publicationsLea J. Mertens16 publicationsMalievskaia E16 publicationsManish Agrawal16 publicationsNadav Liam Modlin16 publicationsSophia Armand16 publicationsYale University16 publicationsAnna M. Becker15 publicationsCharles S. Grob15 publicationsEmmanuelle A. D. Schindler15 publicationsFelix Hasler15 publicationsGerhard Gründer15 publicationsJennifer Jones15 publicationsJoshua S. Siegel15 publicationsKelly JR15 publicationsLindsey Marwood15 publicationsSuresh Muthukumaraswamy15 publicationsTzuri Lifschytz15 publicationsUniversity Hospital15 publicationsBoadie W. Dunlop14 publicationsBrandon Weiss14 publicationsChristopher Pittenger14 publicationsDanica E. Johnson14 publicationsFederico Seragnoli14 publicationsGregor Hasler14 publicationsHenrik Jungaberle14 publicationsJanis Fricke14 publicationsJeng-Yu Tsai14 publicationsJochen Gartz14 publicationsJosé Carlos Bouso14 publicationsMeg J Spriggs14 publications